Effect of Nrf2/HO-1 signaling pathway in intestinal protection by Sishen Pills against ulcerative colitis in mice.
10.19540/j.cnki.cjcmm.20210524.402
- Author:
Xue-Xia ZHANG
1
;
Jian-Wen JIN
2
;
Chang-He LIU
1
;
Min ZHOU
3
;
Ying-Xin HE
3
;
Fei WANG
1
;
Fang-Zhou LIU
1
Author Information
1. Henan Academy of Chinese Medicine Zhengzhou 450004, China.
2. Henan Provincial Food and Drug Evaluation and Inspection Center Zhengzhou 450004, China.
3. Zhengzhou University Zhengzhou 450001, China.
- Publication Type:Journal Article
- Keywords:
HO-1;
NQO-1;
Nrf2;
Sishen Pills;
ulcerative colitis(UC)
- MeSH:
Animals;
Colitis, Ulcerative/genetics*;
Dextran Sulfate;
Heme Oxygenase-1/metabolism*;
Mice;
NF-E2-Related Factor 2/metabolism*;
Signal Transduction
- From:
China Journal of Chinese Materia Medica
2021;46(16):4187-4192
- CountryChina
- Language:Chinese
-
Abstract:
The present study aimed to explore the effect of nuclear factor erythroid 2 related factor 2(Nrf2)/heme oxygenase-1(HO-1) signaling pathway in intestinal protection by Sishen Pills against ulcerative colitis(UC). After the UC model was induced by 3% dextran sodium sulfate(DSS), experimental animals were randomly divided into control group, model group, salazosulfapyridine(SASP) group, and low-and high-dose Sishen Pills groups. Drug intervention(ig) was performed for seven consecutive days during modeling. On the 7 th day, the mice were euthanized. The body weight and colon length were recorded, and the histopathological changes of the colon were observed by HE staining. Serum interleukin-6(IL-6), tumor necrosis factor-α(TNF-α), total antioxidant capacity(T-AOC), malondialdehyde(MDA), and reactive oxygen species(ROS) were detected by ELISA. The protein and mRNA expression of Nrf2, HO-1, and NADPH quinine oxidoreductase-1(NQO-1) was determined by Western blot and reverse transcription-polymerase chain reaction(RT-PCR). Compared with the normal group, the model group exhibited reduced body weight, colon length, and T-AOC, increased IL-6, TNF-α, MDA, and ROS, and diminished protein and mRNA expression of Nrf2, HO-1, and NQO-1 in the colon tissues. Compared with the model group, the SASP group and high-dose Sishen Pills group showed elevated body weight, colon length, and T-AOC, lowered IL-6, TNF-α, MDA, and ROS levels, and increased protein and mRNA expression of Nrf2, HO-1, and NQO-1 in the colon tissues. As assessed by HE staining, Sishen Pills could improve the pathological changes of the colon. The findings suggested that Sishen Pills could protect the colon against UC induced by 3% DSS. The specific mechanism of action may be related to the anti-inflammatory and anti-oxidative stress effects by the activation of the Nrf2/HO-1 signaling pathway.
